Trademarkia Logo

Australia

AU$
Trademark Search
SYNAPLIN

View On IPO.GOV.AU

SYNAPLIN
Removed - Not renewed: Renewal fee not paid

Last updated on 17 Jan 2019

Owner Info

Biogen MA Inc.

14 Cambridge Center

Cambridge, UNITED STATES OF AMERICA

Serial Number

1250510 filed on 9 Jul 2008

Correspondent

Herbert Smith Freehills

Level 24,,

80 Collins Street,

MELBOURNE, VIC, 3000 AUSTRALIA

SYNAPLIN

Classification Information

Class [005]
Pharmaceutical preparations for use in the treatment of autoimmune disorders, neurological disorders, cardiovascular disorders, oncological disorders, Read More

Mark Details

Serial Number

1250510

Registered On

9 Jul 2008

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

13 Feb 2008

Mark Type

US

Legal History

Show more

Status DateAction Taken
17th Jan 2019IP Right Ceased correspondence sent
17th Jan 2019Status change to Removed/Ceased - Not Renewed
23rd Jul 2018Registration Status Change
7th May 2018Renewal Reminder correspondence sent
10th Jul 2017Registration Status Change
9th Apr 2015IP Right Name Amendment Published
1st Apr 2015Amend Name/Address
27th Mar 2015Amendment to Application/Registration
11th Dec 2008IP Right Registration Published
24th Nov 2008Application Status